Q2 2016 Holdings
Filed 2016-08-12 | 63 holdings | $38.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $8.6M | 110,000 | 22.4% |
| Conmed Corp(CNMD) | COM | 207410101 | $8.4M | 175,000 | 21.9% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $7.6M | 325,000 | 19.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $7.3M | 30,000 | 19.0% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $4.8M | 1,700,000 | 12.6% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $1.3M | 100,000 | 3.5% |
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $40.2K | 350,000 | 0.1% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $21.6K | 400,000 | 0.1% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $20.9K | 100,000 | 0.1% |
| GW Pharmaceuticals PLCPut | ADS | 36197T103 | $11.9K | 130,000 | 0.0% |
| Ophthotech Corp | COM | 683745103 | $11.0K | 215,000 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $10.5K | 90,000 | 0.0% |
| Nuvasive Inc(NUVAGBP) | COM | 670704105 | $9.0K | 150,000 | 0.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $8.7K | 100,000 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $8.5K | 85,000 | 0.0% |
| Acorda Therapeutics Inc | COM | 00484M106 | $8.3K | 325,000 | 0.0% |
| Boston Scientific Corp(BSX)Call | COM | 101137107 | $8.2K | 350,000 | 0.0% |
| Axovant Sciences LTD | COM | G0750W104 | $7.4K | 575,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $7.4K | 170,000 | 0.0% |
| Spectranetics Corp | COM | 84760C107 | $7.0K | 375,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR)Put | COM | 189464100 | $6.9K | 500,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $6.2K | 450,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $5.9K | 80,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT)Put | COM | 803607100 | $5.7K | 300,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $5.7K | 125,000 | 0.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $5.7K | 700,000 | 0.0% |
| K2m Group Hldgs Inc | COM | 48273J107 | $5.4K | 350,000 | 0.0% |
| Genomic Health Inc(GHDX) | COM | 37244C101 | $5.2K | 200,000 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD)Call | COM | 45845P108 | $5.0K | 35,000 | 0.0% |
| Endologix Inc | COM | 29266S106 | $5.0K | 400,000 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $4.7K | 120,000 | 0.0% |
| Sage Therapeutics Inc(SG7)Call | COM | 78667J108 | $4.5K | 150,000 | 0.0% |
| Wright MED Group N V | ORD SHS 0.03 PAR | N96617118 | $4.3K | 250,000 | 0.0% |
| Tesaro IncCall | COM | 881569107 | $4.2K | 50,000 | 0.0% |
| Tesaro Inc | COM | 881569107 | $4.2K | 50,000 | 0.0% |
| Horizon Pharma PLC | SHS | G4617B105 | $4.1K | 250,000 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $4.0K | 120,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $3.8K | 200,000 | 0.0% |
| Flamel Technologies SA | SPONSORED ADR | 338488109 | $3.8K | 350,000 | 0.0% |
| Horizon Pharma PLCCall | SHS | G4617B105 | $3.3K | 200,000 | 0.0% |
| Raptor Pharmaceutical Corp | COM | 75382F106 | $3.2K | 600,000 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $3.2K | 250,000 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $2.5K | 25,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $2.3K | 1,000,000 | 0.0% |
| Entellus MED Inc | COM | 29363K105 | $2.2K | 120,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $1.9K | 100,000 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $1.8K | 12,700 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $1.8K | 800,000 | 0.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $1.7K | 341,708 | 0.0% |
| Fluidigm Corp del(LAB) | COM | 34385P108 | $1.4K | 150,000 | 0.0% |